Acute Physiology and Chronic Health Evaluation II score of ≥15: A risk factor for sepsis-induced critical illness polyneuropathy

Neurology India

Volumn 64, Issue 4, 2016, Pages 640-645

  Gupta, Salil ^a   Mishra, Mayank ^b  

^a Medical Division   (India)

^b MILITARY HOSPITAL   (India)

Author keywords

Acute physiology and chronic health evaluation II; Critical illness polyneuropathy; Risk factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C; POTASSIUM; PROTEIN;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICAL ILLNESS POLYNEUROPATHY; CRITICALLY ILL PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; RISK ASSESSMENT; SEPSIS; COMPLICATION; INTENSIVE CARE UNIT; POLYNEUROPATHY; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

APACHE; COHORT STUDIES; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; POLYNEUROPATHIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84978828184     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.185356     Document Type: Article

References (13)

1. De Letter MA, van Doorn PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, et al. Critical illness polyneuropathy and myopathy (CIPNM): Evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000;106:206-13.
2. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: A major cause of muscle weakness and paralysis. Lancet Neurol 2011;10:931-41.
3. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 2008;12:238.
4. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al. Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-96.
5. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.
6. Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 2005;252:343-51.
7. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993;33:94-100.
8. Brunner R, Rinner W, Haberler C, Kitzberger R, Sycha T, Herkner H, et al. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: A prospective, randomized, placebo-controlled, double-blinded trial. Crit Care 2013;17:R213.
9. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006;67:1421-5.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
11. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005;33:349-54.
12. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005;11:126-32.
13. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol 2003;106:75-82.